BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1233270)

  • 1. Absorption of digoxin from the distal parts of the intestine in man.
    Ochs H; Bodem G; Schäfer PK; Kodrat G; Dengler HJ
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):95-7. PubMed ID: 1233270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption of beta-methyl-digoxin determined after a single dose and under steady state conditions.
    Boerner D; Olcay A; Schaumann W; Weiss W
    Eur J Clin Pharmacol; 1976 Feb; 9(4):307-14. PubMed ID: 971714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis.
    Almer S; Franzén L; Olaison G; Smedh K; Ström M
    Gut; 1993 Apr; 34(4):509-13. PubMed ID: 8491399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intestinal absorption of digoxin in systemic sclerosis (author's transl)].
    Brachtel R; Gilfrich HJ
    Klin Wochenschr; 1977 May; 55(9):439-44. PubMed ID: 875317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of some organic solvents on the absorption of digoxin by man.
    Fowle AS; French J; O'Grady J
    Arzneimittelforschung; 1981; 31(6):1029-31. PubMed ID: 7196235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.
    Hinderling PH; Garrett ER; Wester RC
    J Pharm Sci; 1977 Mar; 66(3):314-25. PubMed ID: 845795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absorption and urinary excretion of digoxin in the presence of hyoscine butyl bromide and sulpiride in healthy subjects].
    Jiménez Alonso J; Castillo-Ferrando JR; Bolaños J; Jaimez L; Pérez Jiménez F
    Rev Esp Cardiol; 1983; 36(2):121-3. PubMed ID: 6622791
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption of orally administered digoxin after massive resection of the small bowel.
    Krausz MM; Berry E; Freund U; Levy M
    Am J Gastroenterol; 1979 Feb; 71(2):220-3. PubMed ID: 433908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on digoxin absorption from small bowel resections.
    Kumer KP; Nwangwu JT; Nwangwu PU
    Drug Intell Clin Pharm; 1983 Feb; 17(2):121-3. PubMed ID: 6825564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of digoxin: some pitfalls and problems.
    Keller F; Rietbrock N
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):549-56. PubMed ID: 23358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of digoxin and beta-methyl-digoxin.
    Padeletti L; Fantini F; Cinelli P; Gremigni C
    J Int Med Res; 1976; 4(5):352-4. PubMed ID: 1028636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of digoxin tablets in patients with gastrointestinal dysfunction.
    Gerson CD; Lowe EH; Lindenbaum J
    Am J Med; 1980 Jul; 69(1):43-9. PubMed ID: 7386507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].
    Bodem G; Ochs H; Hahn E; Dengler HJ
    Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of digoxin absorption but not of digitoxin during cytostatic drug therapy.
    Kuhlmann J
    Arzneimittelforschung; 1982; 32(6):698-704. PubMed ID: 6889430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of kaolin--pectin suspension on digoxin bioavailability.
    Albert KS; Ayres JW; DiSanto AR; Weidler DJ; Sakmar E; Hallmark MR; Stoll RG; DeSante KA; Wagner JG
    J Pharm Sci; 1978 Nov; 67(11):1582-6. PubMed ID: 712596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sulfasalazine on digoxin bioavailability.
    Juhl RP; Summers RW; Guillory JK; Blaug SM; Cheng FH; Brown DD
    Clin Pharmacol Ther; 1976 Oct; 20(4):387-94. PubMed ID: 10123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease.
    Thomas P; Richards D; Richards A; Rogers L; Evans BK; Dew MJ; Rhodes J
    J Pharm Pharmacol; 1985 Oct; 37(10):757-8. PubMed ID: 2867153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.